Insider Selling: Liquidia (NASDAQ:LQDA) CFO Sells $5,595,114.60 in Stock

Liquidia Corporation (NASDAQ:LQDA) CFO Michael Kaseta sold 139,390 shares of the company’s stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $40.14, for a total transaction of $5,595,114.60. Following the completion of the sale, the chief financial officer owned 353,356 shares of the company’s stock, valued at approximately $14,183,709.84. The trade was a 28.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Kaseta also recently made the following trade(s):

• On Tuesday, April 14th, Michael Kaseta sold 3,000 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total transaction of $120,000.00.
• On Monday, April 13th, Michael Kaseta sold 18,958 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total transaction of $727,418.46.
• On Friday, April 10th, Michael Kaseta sold 23,821 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total transaction of $956,174.94.
• On Thursday, April 9th, Michael Kaseta sold 133,789 shares of Liquidia stock. The stock was sold at an average price of $40.24, for a total transaction of $5,383,669.36.

Liquidia Stock Performance

NASDAQ LQDA opened at $39.47 on Friday. The company has a fifty day moving average price of $36.55 and a 200-day moving average price of $33.33. The firm has a market cap of $3.48 billion, a price-to-earnings ratio of -47.55 and a beta of 0.45. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $46.67. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Thursday, March 5th. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.07. The business had revenue of $92.02 million for the quarter, compared to analyst estimates of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.Liquidia’s revenue for the quarter was up 3072.4% compared to the same quarter last year. As a group, equities research analysts predict that Liquidia Corporation will post -1.51 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on LQDA shares. HC Wainwright increased their price target on shares of Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Wells Fargo & Company increased their price target on shares of Liquidia from $44.00 to $51.00 and gave the company an “overweight” rating in a research report on Monday, March 23rd. Oppenheimer increased their price target on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a research report on Thursday, March 12th. Zacks Research lowered shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 27th. Finally, BTIG Research increased their price target on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $43.44.

Hedge Funds Weigh In On Liquidia

Several institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Liquidia by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after purchasing an additional 1,700 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Liquidia by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after purchasing an additional 16,022 shares during the last quarter. Creative Planning lifted its holdings in Liquidia by 40.7% during the second quarter. Creative Planning now owns 26,840 shares of the company’s stock valued at $334,000 after purchasing an additional 7,765 shares during the last quarter. Finally, Legal & General Group Plc lifted its holdings in Liquidia by 13.4% during the second quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock valued at $1,174,000 after purchasing an additional 11,111 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Key Headlines Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Earnings beat and improving near‑term fundamentals — Liquidia reported quarterly revenue and EPS above consensus, which supports the company’s growth thesis and likely attracted buyer interest ahead of the pullback. MarketBeat: Liquidia Stock
• Positive Sentiment: Analyst support remains constructive — several firms have raised price targets or reiterated buy/overweight opinions recently, providing research‑driven demand that can limit downside. MarketBeat: Analyst Coverage
• Neutral Sentiment: High institutional ownership (~64.5%) — large holders can stabilize the share price; insider sales don’t automatically become sustained selling if institutions remain supportive. MarketBeat: Institutional Holdings
• Negative Sentiment: Concentrated insider selling by C‑suite — multiple sizable sales from CFO Michael Kaseta (including multi‑hundred‑thousand and multi‑million dollar blocks) have been disclosed and are likely the main reason shares pulled back today; the volume and visibility of these sales can damage sentiment. InsiderTrades: Kaseta Sale
• Negative Sentiment: CEO and other officers also sold under 10b5‑1 plans — Roger Jeffs disclosed multi‑date sales (including a 25,000‑share block), reinforcing the perception of distributed insider exits that can cap near‑term upside even if planned. SEC Filing: Jeffs Sale

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).